Stoke Therapeutics (STOK) Reiterated at Overweight by Cantor Fitzgerald Jan 12, 2026 07:45AM
Cantor Fitzgerald Reiterates Overweight Rating on Stoke Therapeutics (STOK) Jan 5, 2026 07:54AM
Cantor Fitzgerald Reiterates Overweight Rating on Stoke Therapeutics (STOK) Jan 8, 2025 06:36AM
Stoke Therapeutics to Present at Upcoming Investor Conferences in September Sep 3, 2024 08:00AM
Stoke Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Nov 24, 2020 04:01PM


Nov 20, 2020 05:54AM Stoke Therapeutics Inc. (STOK) Prices 2.5M Share Common Offering at $39/Sh
Nov 19, 2020 07:00PM Stoke Therapeutics Announces Pricing of $97.5 Million Public Offering
Nov 18, 2020 04:02PM Stoke Therapeutics Inc. (STOK) Announces 2.5M Share Proposed Public Offering
Nov 18, 2020 04:02PM Stoke Therapeutics Announces Proposed Public Offering
Oct 23, 2020 06:44AM Cantor Fitzgerald Starts Stoke Therapeutics (STOK) at Overweight, Bullish on TANGO Platform